MX9102325A - PHARMACEUTICAL DOSAGE FORMS OF ALMACALANTE AND PROCEDURE FOR THEIR OBTAINING. - Google Patents

PHARMACEUTICAL DOSAGE FORMS OF ALMACALANTE AND PROCEDURE FOR THEIR OBTAINING.

Info

Publication number
MX9102325A
MX9102325A MX9102325A MX9102325A MX9102325A MX 9102325 A MX9102325 A MX 9102325A MX 9102325 A MX9102325 A MX 9102325A MX 9102325 A MX9102325 A MX 9102325A MX 9102325 A MX9102325 A MX 9102325A
Authority
MX
Mexico
Prior art keywords
almacalante
procedure
obtaining
dosage forms
pharmaceutical dosage
Prior art date
Application number
MX9102325A
Other languages
Spanish (es)
Inventor
Kjell Hjalmar Andersson
Per Johan
Gunnar Lundberg
Leif Roger
Simonsson Karin Hele Johansson
Wingstrand
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of MX9102325A publication Critical patent/MX9102325A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/795—Polymers containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Chemical Treatment Of Metals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX9102325A 1990-12-07 1991-12-02 PHARMACEUTICAL DOSAGE FORMS OF ALMACALANTE AND PROCEDURE FOR THEIR OBTAINING. MX9102325A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9003902A SE9003902D0 (en) 1990-12-07 1990-12-07 SOLID DOSAGE FORMS OF A DRUG

Publications (1)

Publication Number Publication Date
MX9102325A true MX9102325A (en) 1992-06-01

Family

ID=20381121

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9102325A MX9102325A (en) 1990-12-07 1991-12-02 PHARMACEUTICAL DOSAGE FORMS OF ALMACALANTE AND PROCEDURE FOR THEIR OBTAINING.

Country Status (27)

Country Link
EP (1) EP0560821A1 (en)
JP (1) JPH06503312A (en)
CN (1) CN1063039A (en)
AP (1) AP258A (en)
AU (1) AU8930791A (en)
BG (1) BG97851A (en)
CA (1) CA2097178A1 (en)
CZ (1) CZ103793A3 (en)
FI (1) FI932554A7 (en)
HU (1) HUT64217A (en)
IE (1) IE914137A1 (en)
IL (1) IL100150A0 (en)
IS (1) IS3788A7 (en)
LT (1) LTIP1717A (en)
MA (1) MA22355A1 (en)
MX (1) MX9102325A (en)
MY (1) MY106776A (en)
NO (1) NO932052D0 (en)
NZ (1) NZ240731A (en)
PT (1) PT99719A (en)
SE (1) SE9003902D0 (en)
SK (1) SK55693A3 (en)
TN (1) TNSN91117A1 (en)
TW (1) TW215057B (en)
WO (1) WO1992010172A1 (en)
YU (1) YU186891A (en)
ZA (1) ZA919264B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19602757A1 (en) * 1996-01-26 1997-07-31 Boehringer Mannheim Gmbh Solid instant release dosage forms and processes for their manufacture
GB9611328D0 (en) * 1996-05-31 1996-08-07 Zeneca Ltd Pharmaceutical compositions
US6024981A (en) * 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
JP4504467B2 (en) * 1998-07-30 2010-07-14 佐藤製薬株式会社 Orally disintegrating tablets
JP7426685B2 (en) * 2018-06-14 2024-02-02 株式会社東洋新薬 tablet

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8705150D0 (en) * 1987-12-23 1987-12-23 Haessle Ab NOVEL ANTIARRHYTHMIC AGENTS
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorbate comprising ranitidine together with a synthetic cation exchange resin, its preparation and pharmaceutical compositions containing it
SE8902236D0 (en) * 1989-06-20 1989-06-20 Haessle Ab NOVEL POLYSTYRENESULPHONATE

Also Published As

Publication number Publication date
AU8930791A (en) 1992-07-08
HU9301670D0 (en) 1993-09-28
IE914137A1 (en) 1992-06-17
NZ240731A (en) 1993-10-26
ZA919264B (en) 1992-08-26
PT99719A (en) 1992-10-30
IS3788A7 (en) 1992-06-08
LTIP1717A (en) 1995-07-25
EP0560821A1 (en) 1993-09-22
BG97851A (en) 1994-04-29
YU186891A (en) 1994-04-05
WO1992010172A1 (en) 1992-06-25
FI932554L (en) 1993-06-08
MY106776A (en) 1995-07-31
HUT64217A (en) 1993-12-28
NO932052L (en) 1993-06-04
MA22355A1 (en) 1992-07-01
AP9100338A0 (en) 1992-01-31
JPH06503312A (en) 1994-04-14
CA2097178A1 (en) 1992-06-08
IL100150A0 (en) 1992-08-18
CN1063039A (en) 1992-07-29
SK55693A3 (en) 1993-10-06
FI932554A7 (en) 1993-06-08
TNSN91117A1 (en) 1992-10-25
AP258A (en) 1993-06-03
TW215057B (en) 1993-10-21
NO932052D0 (en) 1993-06-04
CZ103793A3 (en) 1994-02-16
SE9003902D0 (en) 1990-12-07

Similar Documents

Publication Publication Date Title
MX9205280A (en) DERIVATIVES OF BENZANILIDE, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM.
MX23672A (en) DERIVATIVES OF GLYCOPEPTIDES AND PROCEDURE FOR ITS PREPARATION.
ES551441A0 (en) PROCEDURE FOR THE TREATMENT OF PHARMACEUTICAL DOSAGE FORMS
MX9202982A (en) DERIVATIVES OF THE ACIDS QUINOLON - AND NAFTIRIDON - CARBOXYLICS, PROCEDURE FOR THEIR OBTAINING AND MEDICINES THAT CONTAIN THEM.
MX9204301A (en) ACILMERCAPTOALCANOILDIPEPTIDOS, METHODS OF PREPARATION AND ITS THERAPEUTIC USE.
MX9102353A (en) N, O-SULPHATES OF HEPAROSANES, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINED IN THEM.
MX9202743A (en) DERIVATIVES OF BENZAZEPINE AND PROCEDURE FOR ITS PREPARATION.
MX9205392A (en) TRIAZOLCARBOZAMIDES HERBICIDES AND PROCEDURE FOR THEIR OBTAINING.
FI923548A7 (en) Foam-forming composition for pharmaceutical use, its use and method of treatment
IT1183060B (en) PREPARATION PROCEDURE. CEFEM PHARMACEUTICAL AND RELATED COMPOUNDS
AR002982A1 (en) Benzonitriles and benzofluorides, a procedure to prepare them, their use to prepare drugs, a drug made from these compounds, the pharmaceutical preparations containing them and a procedure to obtain these pharmaceutical preparations.
MX9202022A (en) DERIVATIVES OF PIRAZINE AND PROCESS FOR ITS PREPARATION.
IT7919434A0 (en) PHARMACEUTICAL FORMS MADE UP OF LIPOSOMES AND RELATED PROCEDURES.
MX9201847A (en) HETEROCICLIC DERIVATIVES OF ANTISEROTONINS, PROCEDURE FOR THE PREPARATION AND MEDICINES THAT CONTAIN THEM.
IT1143009B (en) PHARMACEUTICAL COMPOUNDS WITH ANTI-SECRET ACTION AND PREPARATION PROCEDURE
MX9201780A (en) OXIMIC ETERES AND PROCEDURE FOR ITS PREPARATION.
DE3582594D1 (en) PROGLUMID AND ITS PHARMACEUTICAL COMPOSITIONS FOR USE IN THE TREATMENT OF NEOPLASTIC AFFECTIONS.
MX9203836A (en) DERIVATIVES OF ACID-4-AMINO-3-HYDROXICARBOXILICO AND PROCESS FOR ITS PREPARATION.
MX9100742A (en) PHARMACEUTICAL COMPOSITION AND PROCEDURE FOR ITS PREPARATION
MX9100357A (en) STABILIZED PHARMACEUTICAL COMPOSITIONS AND PROCEDURE FOR THE PREPARATION
MX9102325A (en) PHARMACEUTICAL DOSAGE FORMS OF ALMACALANTE AND PROCEDURE FOR THEIR OBTAINING.
MX9102499A (en) DERIVATIVES OF BENZAMIDE, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM.
MX9205746A (en) PIRAZOLINES AND PROCEDURE FOR ITS PREPARATION.
MX9201912A (en) NEW SULFONAMIDES, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATION CONTAINING THEM.
MX9204747A (en) DERIVATIVES OF BENZOTIAZOLONE AND PROCEDURE FOR ITS PREPARATION.